| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 7.06e-08 | 43 | 19 | 4 | GO:0030280 | |
| GeneOntologyMolecularFunction | structural molecule activity | 1.21e-03 | 891 | 19 | 5 | GO:0005198 | |
| GeneOntologyBiologicalProcess | keratinization | LCE1C LCE1B LCE1E LCE1D SPRR2A SPRR2B LCE1A SPRR2D SPRR2E SPRR2F SPRR2G LCE3A LCE1F LCE5A | 2.13e-29 | 87 | 21 | 14 | GO:0031424 |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | LCE1C LCE1B LCE1E LCE1D SPRR2A SPRR2B LCE1A SPRR2D SPRR2E SPRR2F SPRR2G LCE3A LCE1F LCE5A | 1.98e-24 | 189 | 21 | 14 | GO:0030216 |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | LCE1C LCE1B LCE1E LCE1D SPRR2A SPRR2B LCE1A SPRR2D SPRR2E SPRR2F SPRR2G LCE3A LCE1F LCE5A | 6.81e-22 | 284 | 21 | 14 | GO:0009913 |
| GeneOntologyBiologicalProcess | skin development | LCE1C LCE1B LCE1E LCE1D SPRR2A SPRR2B LCE1A SPRR2D SPRR2E SPRR2F SPRR2G LCE3A LCE1F LCE5A | 3.25e-20 | 373 | 21 | 14 | GO:0043588 |
| GeneOntologyBiologicalProcess | epidermis development | LCE1C LCE1B LCE1E LCE1D SPRR2A SPRR2B LCE1A SPRR2D SPRR2E SPRR2F SPRR2G LCE3A LCE1F LCE5A | 6.44e-19 | 461 | 21 | 14 | GO:0008544 |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | LCE1C LCE1B LCE1E LCE1D SPRR2A SPRR2B LCE1A SPRR2D SPRR2E SPRR2F SPRR2G LCE3A LCE1F NOTCH4 LCE5A | 9.06e-17 | 870 | 21 | 15 | GO:0030855 |
| GeneOntologyBiologicalProcess | epithelium development | LCE1C LCE1B LCE1E LCE1D SPRR2A SPRR2B LCE1A SPRR2D SPRR2E SPRR2F SPRR2G LCE3A LCE1F NOTCH4 LCE5A | 2.07e-13 | 1469 | 21 | 15 | GO:0060429 |
| GeneOntologyBiologicalProcess | response to estradiol | 7.80e-06 | 128 | 21 | 4 | GO:0032355 | |
| GeneOntologyCellularComponent | cornified envelope | 3.49e-14 | 69 | 16 | 7 | GO:0001533 | |
| GeneOntologyCellularComponent | secretory vesicle | 2.11e-04 | 1246 | 16 | 6 | GO:0099503 | |
| GeneOntologyCellularComponent | lipid droplet | 3.48e-03 | 116 | 16 | 2 | GO:0005811 | |
| GeneOntologyCellularComponent | secretory granule | 6.27e-03 | 1014 | 16 | 4 | GO:0030141 | |
| GeneOntologyCellularComponent | transport vesicle | 6.70e-03 | 519 | 16 | 3 | GO:0030133 | |
| MousePheno | increased total body fat amount | 3.05e-07 | 424 | 11 | 6 | MP:0010024 | |
| MousePheno | decreased bone mineral content | 5.26e-07 | 465 | 11 | 6 | MP:0010124 | |
| MousePheno | abnormal bone mineral content | 6.39e-06 | 713 | 11 | 6 | MP:0010122 | |
| MousePheno | abnormal adipose tissue amount | 6.80e-05 | 1077 | 11 | 6 | MP:0005452 | |
| MousePheno | abnormal adipose tissue morphology | 2.53e-04 | 1361 | 11 | 6 | MP:0000003 | |
| MousePheno | abnormal bone structure | 2.72e-04 | 1379 | 11 | 6 | MP:0003795 | |
| MousePheno | adipose tissue phenotype | 2.76e-04 | 1383 | 11 | 6 | MP:0005375 | |
| MousePheno | decreased mean corpuscular hemoglobin concentration | 4.88e-03 | 136 | 11 | 2 | MP:0005642 | |
| Domain | SPRR/LCE | LCE1C LCE1B LCE1E LCE1D SPRR2A SPRR2B LCE1A SPRR2D SPRR2E SPRR2F LCE3A LCE1F LCE5A | 5.37e-34 | 28 | 20 | 13 | IPR026075 |
| Domain | LCE | 8.31e-21 | 17 | 20 | 8 | PF14672 | |
| Domain | LCE | 8.31e-21 | 17 | 20 | 8 | IPR028205 | |
| Domain | SPRR2 | 6.58e-19 | 6 | 20 | 6 | IPR029142 | |
| Domain | SPRR2 | 6.58e-19 | 6 | 20 | 6 | PF14820 | |
| Domain | SOCS | 2.05e-04 | 20 | 20 | 2 | SM00253 | |
| Domain | SOCS_box | 7.48e-04 | 38 | 20 | 2 | PF07525 | |
| Domain | SOCS_box | 7.88e-04 | 39 | 20 | 2 | IPR001496 | |
| Domain | SOCS | 7.88e-04 | 39 | 20 | 2 | PS50225 | |
| Domain | SOCS_box | 7.88e-04 | 39 | 20 | 2 | SM00969 | |
| Domain | RAB | 2.74e-03 | 73 | 20 | 2 | PS51419 | |
| Domain | EGF_CA | 3.77e-03 | 86 | 20 | 2 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 4.77e-03 | 97 | 20 | 2 | IPR018097 | |
| Domain | EGF_CA | 4.97e-03 | 99 | 20 | 2 | PS01187 | |
| Domain | ASX_HYDROXYL | 5.06e-03 | 100 | 20 | 2 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 5.67e-03 | 106 | 20 | 2 | IPR000152 | |
| Domain | EGF_CA | 7.45e-03 | 122 | 20 | 2 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 7.68e-03 | 124 | 20 | 2 | IPR001881 | |
| Domain | Ras | 9.18e-03 | 136 | 20 | 2 | PF00071 | |
| Domain | Growth_fac_rcpt_ | 1.19e-02 | 156 | 20 | 2 | IPR009030 | |
| Domain | Small_GTPase | 1.25e-02 | 160 | 20 | 2 | IPR001806 | |
| Domain | Small_GTP-bd_dom | 1.36e-02 | 167 | 20 | 2 | IPR005225 | |
| Domain | EGF | 2.58e-02 | 235 | 20 | 2 | SM00181 | |
| Domain | EGF_3 | 2.58e-02 | 235 | 20 | 2 | PS50026 | |
| Domain | EGF-like_dom | 2.87e-02 | 249 | 20 | 2 | IPR000742 | |
| Domain | EGF_1 | 3.00e-02 | 255 | 20 | 2 | PS00022 | |
| Domain | EGF-like_CS | 3.13e-02 | 261 | 20 | 2 | IPR013032 | |
| Domain | EGF_2 | 3.22e-02 | 265 | 20 | 2 | PS01186 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | LCE1C LCE1B LCE1E LCE1D SPRR2A SPRR2B LCE1A SPRR2D SPRR2E SPRR2F SPRR2G LCE3A LCE1F LCE5A | 1.57e-25 | 129 | 19 | 14 | M27649 |
| Pathway | REACTOME_KERATINIZATION | LCE1C LCE1B LCE1E LCE1D SPRR2A SPRR2B LCE1A SPRR2D SPRR2E SPRR2F SPRR2G LCE3A LCE1F LCE5A | 2.99e-22 | 217 | 19 | 14 | M27640 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | LCE1C LCE1B LCE1E LCE1D SPRR2A SPRR2B LCE1A SPRR2D SPRR2E SPRR2F SPRR2G LCE3A LCE1F LCE5A | 8.35e-11 | 1432 | 19 | 14 | M509 |
| Pubmed | 1.92e-21 | 22 | 22 | 8 | 15854049 | ||
| Pubmed | Differentially expressed late constituents of the epidermal cornified envelope. | 2.94e-21 | 23 | 22 | 8 | 11698679 | |
| Pubmed | Estrogen regulates the expression of the small proline-rich 2 gene family in the mouse uterus. | 8.50e-19 | 8 | 22 | 6 | 15232223 | |
| Pubmed | 6.37e-18 | 10 | 22 | 6 | 8325635 | ||
| Pubmed | 2.80e-17 | 12 | 22 | 6 | 18643845 | ||
| Pubmed | 2.80e-17 | 12 | 22 | 6 | 9888996 | ||
| Pubmed | The DNA sequence and biological annotation of human chromosome 1. | LCE1C LCE1B LCE1E LCE1D SPRR2A SPRR2B LCE1A SPRR2D SPRR2E SPRR2F SPRR2G LCE3A LCE1F LCE5A | 9.52e-17 | 1031 | 22 | 14 | 16710414 |
| Pubmed | 2.42e-16 | 16 | 22 | 6 | 17410201 | ||
| Pubmed | 7.81e-15 | 9 | 22 | 5 | 11279051 | ||
| Pubmed | 4.20e-12 | 7 | 22 | 4 | 31884525 | ||
| Pubmed | Mouse Sprr locus: a tandem array of coordinately regulated genes. | 8.39e-12 | 8 | 22 | 4 | 12584609 | |
| Pubmed | 8.39e-12 | 8 | 22 | 4 | 15574822 | ||
| Pubmed | 8.39e-12 | 8 | 22 | 4 | 11038185 | ||
| Pubmed | 4.03e-11 | 40 | 22 | 5 | 19864314 | ||
| Pubmed | Assessment of community efforts to advance network-based prediction of protein-protein interactions. | 8.00e-11 | 630 | 22 | 9 | 36949045 | |
| Pubmed | The mineralocorticoid receptor plays a transient role in mouse skin development. | 8.55e-11 | 13 | 22 | 4 | 26268211 | |
| Pubmed | Novel markers of early ovarian pre-granulosa cells are expressed in an Sry-like pattern. | 1.20e-10 | 14 | 22 | 4 | 19301398 | |
| Pubmed | Amniotic fluid activates the nrf2/keap1 pathway to repair an epidermal barrier defect in utero. | 1.20e-10 | 14 | 22 | 4 | 23237955 | |
| Pubmed | 1.63e-10 | 15 | 22 | 4 | 20880987 | ||
| Pubmed | 5.78e-10 | 20 | 22 | 4 | 21466799 | ||
| Pubmed | 8.71e-10 | 22 | 22 | 4 | 16949565 | ||
| Pubmed | 8.71e-10 | 22 | 22 | 4 | 24899573 | ||
| Pubmed | Expression and regulation of cornified envelope proteins in human corneal epithelium. | 8.78e-10 | 4 | 22 | 3 | 16639001 | |
| Pubmed | 8.78e-10 | 4 | 22 | 3 | 29397434 | ||
| Pubmed | 1.51e-09 | 25 | 22 | 4 | 31410202 | ||
| Pubmed | 2.19e-09 | 5 | 22 | 3 | 3133554 | ||
| Pubmed | ZFP750 affects the cutaneous barrier through regulating lipid metabolism. | 3.73e-09 | 31 | 22 | 4 | 37115925 | |
| Pubmed | Ovarian development in mice requires the GATA4-FOG2 transcription complex. | 6.98e-09 | 36 | 22 | 4 | 18927154 | |
| Pubmed | CYSRT1: An Antimicrobial Epidermal Protein that Can Interact with Late Cornified Envelope Proteins. | 7.68e-09 | 7 | 22 | 3 | 36804407 | |
| Pubmed | 5.72e-08 | 60 | 22 | 4 | 31220272 | ||
| Pubmed | 6.54e-08 | 62 | 22 | 4 | 26644517 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 9722562 | ||
| Pubmed | 3.82e-06 | 5 | 22 | 2 | 27909076 | ||
| Pubmed | 6.74e-06 | 197 | 22 | 4 | 32434143 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 1.64e-05 | 910 | 22 | 6 | 36736316 | |
| Pubmed | 3.99e-05 | 15 | 22 | 2 | 18316326 | ||
| Pubmed | Variation in genes of the epidermal differentiation complex in German atopic dermatitis patients. | 7.96e-05 | 21 | 22 | 2 | 19601998 | |
| Pubmed | Notch signaling regulates smooth muscle differentiation of epicardium-derived cells. | 2.24e-04 | 35 | 22 | 2 | 21252157 | |
| Pubmed | 3.09e-04 | 41 | 22 | 2 | 12076535 | ||
| Pubmed | 6.18e-04 | 58 | 22 | 2 | 11856727 | ||
| Interaction | LCE3B interactions | 2.10e-19 | 46 | 21 | 9 | int:LCE3B | |
| Interaction | KRTAP5-2 interactions | 3.84e-18 | 62 | 21 | 9 | int:KRTAP5-2 | |
| Interaction | KRTAP5-4 interactions | 4.48e-18 | 63 | 21 | 9 | int:KRTAP5-4 | |
| Interaction | KRTAP10-11 interactions | 5.21e-18 | 64 | 21 | 9 | int:KRTAP10-11 | |
| Interaction | KRTAP5-11 interactions | 7.00e-18 | 66 | 21 | 9 | int:KRTAP5-11 | |
| Interaction | KRTAP5-3 interactions | 7.00e-18 | 66 | 21 | 9 | int:KRTAP5-3 | |
| Interaction | LCE2D interactions | 2.08e-17 | 74 | 21 | 9 | int:LCE2D | |
| Interaction | KRTAP4-5 interactions | 2.68e-17 | 76 | 21 | 9 | int:KRTAP4-5 | |
| Interaction | LCE4A interactions | 4.35e-17 | 80 | 21 | 9 | int:LCE4A | |
| Interaction | KRTAP4-4 interactions | 4.89e-17 | 81 | 21 | 9 | int:KRTAP4-4 | |
| Interaction | LCE2C interactions | 1.07e-16 | 88 | 21 | 9 | int:LCE2C | |
| Interaction | KRTAP1-5 interactions | 1.11e-16 | 48 | 21 | 8 | int:KRTAP1-5 | |
| Interaction | RGS17 interactions | 1.11e-16 | 48 | 21 | 8 | int:RGS17 | |
| Interaction | KRTAP4-11 interactions | 1.62e-16 | 92 | 21 | 9 | int:KRTAP4-11 | |
| Interaction | KRTAP5-6 interactions | 1.98e-16 | 94 | 21 | 9 | int:KRTAP5-6 | |
| Interaction | KRTAP12-4 interactions | 2.61e-16 | 53 | 21 | 8 | int:KRTAP12-4 | |
| Interaction | KRTAP9-8 interactions | 3.53e-16 | 100 | 21 | 9 | int:KRTAP9-8 | |
| Interaction | SPRY1 interactions | 9.32e-16 | 111 | 21 | 9 | int:SPRY1 | |
| Interaction | KRTAP4-1 interactions | 1.13e-15 | 31 | 21 | 7 | int:KRTAP4-1 | |
| Interaction | KRTAP12-1 interactions | 1.13e-15 | 63 | 21 | 8 | int:KRTAP12-1 | |
| Interaction | LCE1E interactions | 2.16e-15 | 68 | 21 | 8 | int:LCE1E | |
| Interaction | KRTAP4-2 interactions | 4.63e-15 | 132 | 21 | 9 | int:KRTAP4-2 | |
| Interaction | LCE1C interactions | 6.11e-15 | 77 | 21 | 8 | int:LCE1C | |
| Interaction | SMCP interactions | 7.56e-15 | 79 | 21 | 8 | int:SMCP | |
| Interaction | KRTAP9-3 interactions | 7.95e-15 | 140 | 21 | 9 | int:KRTAP9-3 | |
| Interaction | LCE2B interactions | 9.31e-15 | 81 | 21 | 8 | int:LCE2B | |
| Interaction | KRTAP12-3 interactions | 1.17e-14 | 146 | 21 | 9 | int:KRTAP12-3 | |
| Interaction | LCE1B interactions | 1.39e-14 | 85 | 21 | 8 | int:LCE1B | |
| Interaction | TRIM42 interactions | 1.41e-14 | 149 | 21 | 9 | int:TRIM42 | |
| Interaction | KRTAP9-2 interactions | 1.41e-14 | 149 | 21 | 9 | int:KRTAP9-2 | |
| Interaction | KRTAP10-1 interactions | 1.80e-14 | 153 | 21 | 9 | int:KRTAP10-1 | |
| Interaction | LCE5A interactions | 2.23e-14 | 90 | 21 | 8 | int:LCE5A | |
| Interaction | LCE1F interactions | 2.68e-14 | 92 | 21 | 8 | int:LCE1F | |
| Interaction | KRTAP10-5 interactions | 2.71e-14 | 160 | 21 | 9 | int:KRTAP10-5 | |
| Interaction | KRTAP4-12 interactions | 2.86e-14 | 161 | 21 | 9 | int:KRTAP4-12 | |
| Interaction | KRTAP2-3 interactions | 3.49e-14 | 95 | 21 | 8 | int:KRTAP2-3 | |
| Interaction | KRTAP2-4 interactions | 5.78e-14 | 101 | 21 | 8 | int:KRTAP2-4 | |
| Interaction | KRTAP5-9 interactions | 2.37e-13 | 203 | 21 | 9 | int:KRTAP5-9 | |
| Interaction | ALPP interactions | 2.91e-13 | 123 | 21 | 8 | int:ALPP | |
| Interaction | FBLN1 interactions | 4.29e-13 | 129 | 21 | 8 | int:FBLN1 | |
| Interaction | LCE2A interactions | 4.51e-13 | 69 | 21 | 7 | int:LCE2A | |
| Interaction | LCE1D interactions | 5.01e-13 | 70 | 21 | 7 | int:LCE1D | |
| Interaction | CHIC2 interactions | 6.80e-13 | 73 | 21 | 7 | int:CHIC2 | |
| Interaction | HOXA1 interactions | 7.74e-13 | 356 | 21 | 10 | int:HOXA1 | |
| Interaction | NBPF19 interactions | 8.24e-13 | 233 | 21 | 9 | int:NBPF19 | |
| Interaction | KRTAP10-9 interactions | 1.12e-12 | 241 | 21 | 9 | int:KRTAP10-9 | |
| Interaction | LCE1A interactions | 1.88e-12 | 84 | 21 | 7 | int:LCE1A | |
| Interaction | KRTAP10-8 interactions | 2.53e-12 | 401 | 21 | 10 | int:KRTAP10-8 | |
| Interaction | KRTAP6-3 interactions | 2.59e-12 | 161 | 21 | 8 | int:KRTAP6-3 | |
| Interaction | MACO1 interactions | 5.09e-12 | 175 | 21 | 8 | int:MACO1 | |
| Interaction | KRTAP1-3 interactions | 7.62e-12 | 184 | 21 | 8 | int:KRTAP1-3 | |
| Interaction | RGS20 interactions | 2.14e-11 | 118 | 21 | 7 | int:RGS20 | |
| Interaction | CYSRT1 interactions | 2.76e-11 | 511 | 21 | 10 | int:CYSRT1 | |
| Interaction | KRTAP1-1 interactions | 3.08e-11 | 219 | 21 | 8 | int:KRTAP1-1 | |
| Interaction | NOTCH2NLA interactions | 6.76e-11 | 381 | 21 | 9 | int:NOTCH2NLA | |
| Interaction | KRTAP5-7 interactions | 8.02e-11 | 71 | 21 | 6 | int:KRTAP5-7 | |
| Interaction | VASN interactions | 1.85e-10 | 160 | 21 | 7 | int:VASN | |
| Interaction | KRTAP10-6 interactions | 3.00e-10 | 88 | 21 | 6 | int:KRTAP10-6 | |
| Interaction | KRTAP10-7 interactions | 3.13e-10 | 293 | 21 | 8 | int:KRTAP10-7 | |
| Interaction | PTK6 interactions | 8.32e-10 | 104 | 21 | 6 | int:PTK6 | |
| Interaction | ADAMTSL4 interactions | 1.56e-09 | 217 | 21 | 7 | int:ADAMTSL4 | |
| Interaction | VWC2 interactions | 4.58e-09 | 62 | 21 | 5 | int:VWC2 | |
| Interaction | CRCT1 interactions | 6.31e-09 | 66 | 21 | 5 | int:CRCT1 | |
| Interaction | KRTAP10-10 interactions | 1.51e-08 | 27 | 21 | 4 | int:KRTAP10-10 | |
| Interaction | SPRY3 interactions | 4.47e-08 | 35 | 21 | 4 | int:SPRY3 | |
| Interaction | KRTAP5-8 interactions | 5.44e-08 | 8 | 21 | 3 | int:KRTAP5-8 | |
| Interaction | VWC2L interactions | 7.77e-08 | 40 | 21 | 4 | int:VWC2L | |
| Interaction | PLA2G10 interactions | 9.60e-08 | 113 | 21 | 5 | int:PLA2G10 | |
| Interaction | CATSPER1 interactions | 1.66e-07 | 126 | 21 | 5 | int:CATSPER1 | |
| Interaction | KRTAP12-2 interactions | 1.79e-07 | 128 | 21 | 5 | int:KRTAP12-2 | |
| Interaction | GRN interactions | 3.17e-07 | 281 | 21 | 6 | int:GRN | |
| Interaction | OTX1 interactions | 4.65e-07 | 155 | 21 | 5 | int:OTX1 | |
| Interaction | PLSCR2 interactions | 5.41e-07 | 16 | 21 | 3 | int:PLSCR2 | |
| Interaction | LCE3C interactions | 6.40e-07 | 67 | 21 | 4 | int:LCE3C | |
| Interaction | TGFB1 interactions | 6.42e-07 | 317 | 21 | 6 | int:TGFB1 | |
| Interaction | SLC39A7 interactions | 1.18e-06 | 187 | 21 | 5 | int:SLC39A7 | |
| Interaction | KRTAP3-2 interactions | 1.24e-06 | 79 | 21 | 4 | int:KRTAP3-2 | |
| Interaction | POU4F2 interactions | 1.52e-06 | 83 | 21 | 4 | int:POU4F2 | |
| Interaction | KRTAP3-1 interactions | 1.67e-06 | 85 | 21 | 4 | int:KRTAP3-1 | |
| Interaction | CHRD interactions | 2.50e-06 | 94 | 21 | 4 | int:CHRD | |
| Interaction | PLAC8 interactions | 2.81e-06 | 27 | 21 | 3 | int:PLAC8 | |
| Interaction | KRTAP11-1 interactions | 4.35e-06 | 108 | 21 | 4 | int:KRTAP11-1 | |
| Interaction | PCSK5 interactions | 5.03e-06 | 112 | 21 | 4 | int:PCSK5 | |
| Interaction | CYP21A2 interactions | 5.21e-06 | 33 | 21 | 3 | int:CYP21A2 | |
| Interaction | EFEMP2 interactions | 1.09e-05 | 136 | 21 | 4 | int:EFEMP2 | |
| Interaction | FUCA2 interactions | 1.17e-05 | 43 | 21 | 3 | int:FUCA2 | |
| Interaction | KRTAP17-1 interactions | 1.64e-05 | 48 | 21 | 3 | int:KRTAP17-1 | |
| Interaction | PLSCR3 interactions | 1.64e-05 | 48 | 21 | 3 | int:PLSCR3 | |
| Interaction | SPRY2 interactions | 1.68e-05 | 152 | 21 | 4 | int:SPRY2 | |
| Interaction | NECTIN2 interactions | 2.01e-05 | 159 | 21 | 4 | int:NECTIN2 | |
| Interaction | OIT3 interactions | 4.09e-05 | 65 | 21 | 3 | int:OIT3 | |
| Interaction | NUFIP2 interactions | 5.73e-05 | 417 | 21 | 5 | int:NUFIP2 | |
| Interaction | PLSCR4 interactions | 6.27e-05 | 75 | 21 | 3 | int:PLSCR4 | |
| Interaction | LCE3A interactions | 6.53e-05 | 76 | 21 | 3 | int:LCE3A | |
| Interaction | MDFI interactions | 6.63e-05 | 430 | 21 | 5 | int:MDFI | |
| Interaction | NTAQ1 interactions | 6.70e-05 | 431 | 21 | 5 | int:NTAQ1 | |
| Interaction | RAB40AL interactions | 1.23e-04 | 16 | 21 | 2 | int:RAB40AL | |
| Interaction | RAB40A interactions | 1.75e-04 | 19 | 21 | 2 | int:RAB40A | |
| Interaction | EFEMP1 interactions | 2.72e-04 | 123 | 21 | 3 | int:EFEMP1 | |
| Interaction | KRTAP21-2 interactions | 4.72e-04 | 31 | 21 | 2 | int:KRTAP21-2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | LCE1C LCE1B LCE1E LCE1D SPRR2A SPRR2B LCE1A SPRR2D SPRR2E SPRR2F SPRR2G LCE3A LCE1F SMCP SPRR5 LCE5A | 6.83e-29 | 404 | 22 | 16 | chr1q21 |
| Cytoband | 1q21.3 | 1.60e-18 | 117 | 22 | 9 | 1q21.3 | |
| Cytoband | 1q21-q22 | 5.76e-16 | 23 | 22 | 6 | 1q21-q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq22 | 3.07e-03 | 172 | 22 | 2 | chrXq22 | |
| GeneFamily | Late cornified envelope proteins | 3.75e-21 | 18 | 17 | 8 | 627 | |
| GeneFamily | Small proline rich proteins | 1.18e-16 | 11 | 17 | 6 | 1353 | |
| Coexpression | MARTINEZ_TP53_TARGETS_UP | LCE1C LCE1B LCE1E LCE1D SPRR2A SPRR2B LCE1A SPRR2E SPRR2F FBLN2 LCE5A | 1.15e-12 | 694 | 21 | 11 | MM1039 |
| Coexpression | JARDIM_PERASSI_TRIPLE_NEGATIVE_BREAST_CANCER_MOUSE_XENOGRAFT_MELATONIN_UP | 1.65e-12 | 49 | 21 | 6 | MM452 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_UP | LCE1C LCE1B LCE1E LCE1D SPRR2A SPRR2B LCE1A SPRR2E SPRR2F LCE5A | 4.01e-11 | 689 | 21 | 10 | MM1041 |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_UP | 1.46e-09 | 20 | 21 | 4 | MM491 | |
| Coexpression | HUMMERICH_MALIGNANT_SKIN_TUMOR_UP | 2.67e-09 | 23 | 21 | 4 | MM492 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 1.02e-08 | 204 | 21 | 6 | MM966 | |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | 7.51e-06 | 630 | 21 | 6 | MM1038 | |
| Coexpression | SESTO_RESPONSE_TO_UV_C1 | 2.77e-05 | 74 | 21 | 3 | M7933 | |
| Coexpression | DESCARTES_MAIN_FETAL_SQUAMOUS_EPITHELIAL_CELLS | 1.45e-04 | 129 | 21 | 3 | M40122 | |
| Coexpression | BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP | 2.01e-04 | 144 | 21 | 3 | M34020 | |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | 2.49e-04 | 741 | 21 | 5 | MM1037 | |
| CoexpressionAtlas | skin | LCE1C LCE1B LCE1E LCE1D SPRR2B LCE1A SPRR2E SPRR2G LCE1F LCE5A | 2.88e-12 | 456 | 20 | 10 | skin |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_500 | 7.83e-08 | 427 | 20 | 7 | Facebase_ST1_Univ_500 | |
| CoexpressionAtlas | esophagus | 7.88e-08 | 247 | 20 | 6 | esophagus | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_250 | 1.13e-06 | 206 | 20 | 5 | Facebase_ST1_Univ_250 | |
| CoexpressionAtlas | tonsil | 2.27e-05 | 182 | 20 | 4 | tonsil | |
| CoexpressionAtlas | JC_iEC_top-relative-expression-ranked_2500_k-means-cluster#4 | 2.28e-05 | 382 | 20 | 5 | JC_iEC_2500_K4 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchioEpithel_top-relative-expression-ranked_100 | 1.03e-04 | 98 | 20 | 3 | PCBC_ctl_BronchioEpithel_100 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_500 | 1.87e-04 | 120 | 20 | 3 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k1_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_100 | 3.14e-04 | 28 | 20 | 2 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k3_100 | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_500_5 | 9.65e-04 | 49 | 20 | 2 | Facebase_ST1_Univ_500_5 | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_500_4 | 1.03e-03 | 215 | 20 | 3 | Facebase_ST1_Univ_500_4 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_SmallAirwayEpithel_top-relative-expression-ranked_500 | 1.03e-03 | 493 | 20 | 4 | PCBC_ctl_SmallAirwayEpithel_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchioEpithel_top-relative-expression-ranked_500 | 1.06e-03 | 496 | 20 | 4 | PCBC_ctl_BronchioEpithel_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#4_top-relative-expression-ranked_200 | 1.17e-03 | 54 | 20 | 2 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k4_200 | |
| ToppCell | TCGA-Skin-Primary_Tumor|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.67e-16 | 190 | 22 | 9 | e2b26a03c6ab24d9b0f4150c47597be37767d86e | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.67e-16 | 190 | 22 | 9 | 3188c7bd225cbcf46a21e2fb784336cdd9665995 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.67e-16 | 190 | 22 | 9 | 01fb45add4661bc86cd0a34fac35177907152dbb | |
| ToppCell | TCGA-Head_and_Esophagus|World / Sample_Type by Project: Shred V9 | 1.71e-12 | 172 | 22 | 7 | eb18aa179db1818f408c38e442ecfed8582d7dbc | |
| ToppCell | PSB-critical-LOC-Epithelial-Squamous|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.95e-10 | 183 | 22 | 6 | 2cf798a2371c61322484ea16fdfae0acfa94f102 | |
| ToppCell | NS-moderate-d_07-13|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.32e-10 | 195 | 22 | 6 | 088209505a68519ec89f50f0576096da6966bf17 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.46e-10 | 196 | 22 | 6 | 03de28e1c963e99623e8b0e33bf2e8ef67dc3baa | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.60e-10 | 197 | 22 | 6 | 7870c0651caefb0ed13d9f9dab43b5f24d6a9efc | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.60e-10 | 197 | 22 | 6 | e621d4f9d4ba5e3ef17d2b477e5e14ea0251147e | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.60e-10 | 197 | 22 | 6 | d968d7d5608b175bb567ea3a315bf473ec3be459 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Squamous|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.74e-10 | 198 | 22 | 6 | b7495369baba203490c067a58fc8456a778a12e4 | |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Non-Seminoma-_Embryonal_Carcinoma,_Immature_Teratoma,_Mature_Teratoma,_Yolk_Sac_Tumor-3|TCGA-Testes / Sample_Type by Project: Shred V9 | 3.87e-09 | 125 | 22 | 5 | 5f90de494b53ecce6455034f3ed5dccdbb2c29ca | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_2|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.10e-09 | 132 | 22 | 5 | 780a391924f776dc6fbe44ddcf4ae0583a1e2157 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.71e-09 | 135 | 22 | 5 | 366a417f9ef7c0d86e9f262d97bf788f478315ee | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-2|TCGA-Brain / Sample_Type by Project: Shred V9 | 6.61e-09 | 139 | 22 | 5 | 6f6c64eaa1ce84e0aa9a0caa9c4d9bf7afe626df | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-6|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.87e-08 | 171 | 22 | 5 | 0e78389f8f3d54570a6deb3dd307b865b46307e9 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.35e-08 | 179 | 22 | 5 | 2b5f8e109a67c7fc3ec2b83e8f1854160c99283a | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Squamous|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.33e-08 | 192 | 22 | 5 | 103496f428f59683ac3ae6147682c07c30663724 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Squamous|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.51e-08 | 194 | 22 | 5 | 53a34843d529ef395deb27086f71f7049a087bab | |
| ToppCell | critical-Epithelial-Squamous|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.79e-08 | 197 | 22 | 5 | cfbdaada7169afb68455724ae87032ff311b2d89 | |
| ToppCell | NS-control-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.79e-08 | 197 | 22 | 5 | ab965a0ba87efd3329d24a1ec123985f46fc17c0 | |
| ToppCell | moderate-Epithelial-Squamous|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.79e-08 | 197 | 22 | 5 | ab3c90a5b643b45d0b83939c6304b11f567c5d78 | |
| ToppCell | moderate-Epithelial-Squamous|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.79e-08 | 197 | 22 | 5 | 2e13881f917d4f62a5b3e968e41c57e43300d988 | |
| ToppCell | critical-Epithelial-Squamous|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.79e-08 | 197 | 22 | 5 | eccc80d6ab79c46b10108de1cff3abeacfc105cd | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Metaplastic_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 3.74e-07 | 123 | 22 | 4 | 51e49a64fbbf77e2ee21f45fd515d43282b11516 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Metaplastic_Carcinoma-4|TCGA-Breast / Sample_Type by Project: Shred V9 | 3.74e-07 | 123 | 22 | 4 | 11802979943a9205f10facda322fc220d4bf7133 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-7|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.87e-07 | 124 | 22 | 4 | c6e0c45e9ac128540baddfeb4599a0d5ec3f14cb | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Undifferentiated_Pleomorphic_Sarcoma-4|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 4.82e-07 | 131 | 22 | 4 | 2ccf679b5035b7b9cdb9a9a660cad90288592187 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Goblet_2|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.97e-07 | 153 | 22 | 4 | b25629953ff79aff645845376132b12023067b01 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Goblet_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.97e-07 | 153 | 22 | 4 | e9d6b4e895ddb8d6e6c8b043da591ec11365e124 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-4|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.15e-06 | 163 | 22 | 4 | 6a12b802cb181f979ebc72674f3626fb855024e3 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM5-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.24e-06 | 166 | 22 | 4 | 006ced12f69ef13ddcba5a3891ddc7c18c384863 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM5-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.24e-06 | 166 | 22 | 4 | 6bb3410e65c971acc458c472015afcec6de6e310 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.24e-06 | 166 | 22 | 4 | ac28c8cac1e94be0c47fb862c5809c92cdaa11f3 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM5|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.24e-06 | 166 | 22 | 4 | 823ec03714884cb860a1260410feac8c536b6d06 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.33e-06 | 169 | 22 | 4 | 4a5d023ffcf83312d29b1d215eb6b744ef1a0777 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-suprabasal_interpapillary|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-06 | 172 | 22 | 4 | 6ece9bb9f31685c918ca4cb7b82cf6ad1cad48af | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 173 | 22 | 4 | 0f9c1d3298e59e6d22bb3306f0f445f490be8bbd | |
| ToppCell | NS|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.71e-06 | 180 | 22 | 4 | 8472dcce7bc0b7ce428ec17ddf0018f3258f78d2 | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|tumor_Lung / Location, Cell class and cell subclass | 1.87e-06 | 184 | 22 | 4 | b0a251030d127858e68cf164be158f209a4d720f | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.99e-06 | 187 | 22 | 4 | 2ca7928baf0c5e61f7294ed05e6e6f0e0adf9d3f | |
| ToppCell | wk_15-18-Mesenchymal-Mesothelial-Late_mesothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.04e-06 | 188 | 22 | 4 | 38a53f99f1876359983936403aefca93281d10fd | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.21e-06 | 192 | 22 | 4 | 24fb2f1e6f49ab5b71876e105c0ee7f59e7d64e8 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.31e-06 | 194 | 22 | 4 | 614d0c25b56957c70f397abb169fd2a860eb1c06 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Squamous|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.40e-06 | 196 | 22 | 4 | 97e16d9833e4083d719ca7058d5fc9b11edb37e3 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-06 | 197 | 22 | 4 | fb272c9c60ee3d980e528044dc567b4925a23da6 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-06 | 197 | 22 | 4 | 61c0d78b29dc4ad8a84172cbfcdab03f31351d0e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-06 | 197 | 22 | 4 | dcabea5c50c133c9a4e294e447462d0393174ea7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-06 | 197 | 22 | 4 | 2430f31d9312338e0ca23bfc6bdb0365340860fd | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.50e-06 | 198 | 22 | 4 | e06d41a7254a09e037ec404be2d8c352d5cbd7f4 | |
| ToppCell | control-Epithelial-Squamous|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.50e-06 | 198 | 22 | 4 | 6ba669ac1ed275ae309054941b1457e315766faa | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-SCGB3A2+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.50e-06 | 198 | 22 | 4 | 1fe51f4beca0eef4ff117e6edaa646e35c0f9629 | |
| ToppCell | (08)_Brush+PNEC|World / shred by cell type by condition | 2.55e-06 | 199 | 22 | 4 | f2e33cb569c25fc2732722cac295647e9bd8738f | |
| ToppCell | control-Epithelial-Squamous|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.55e-06 | 199 | 22 | 4 | e13dca7a055cdca53dd6c26c04b2a46d58b419b6 | |
| ToppCell | Ciliated_cells-A-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 5.77e-05 | 154 | 22 | 3 | 3b938e23324f7edb56797b4a76fb96ff588142cf | |
| ToppCell | Ciliated_cells-A-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 6.83e-05 | 163 | 22 | 3 | 43194c6127df1ce3d29242f719645de3c11fd7c0 | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_2|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.21e-05 | 166 | 22 | 3 | 8ac0a769be886d16642e7e6334471ebadd1a426b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.34e-05 | 167 | 22 | 3 | 166b7b4ca0663cde6d88219ee0bcc1988d03dab8 | |
| ToppCell | normal_Lung-Fibroblasts-Mesothelial_cells|Fibroblasts / Location, Cell class and cell subclass | 7.34e-05 | 167 | 22 | 3 | 892a2dc83ab5de5a1016402f8e95d2aabf651326 | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.34e-05 | 167 | 22 | 3 | 806d1c00c137da0c5f042adf866873eb6dd4bb27 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.74e-05 | 170 | 22 | 3 | 13a225e32132e9717debb0d64d7c28ada974c3e6 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-5|TCGA-Lung / Sample_Type by Project: Shred V9 | 8.72e-05 | 177 | 22 | 3 | a0c7d08469c513cecf87777c19876884f1511570 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.72e-05 | 177 | 22 | 3 | 7af1a19692f7fe8f691178a4e57d62bc379e3d56 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.47e-05 | 182 | 22 | 3 | 007fa56ed8b91f9af0df2114c00410b2f6cec8b6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.94e-05 | 185 | 22 | 3 | f3fbc3096f85397a959cee17c3c4fcf2d511f3d5 | |
| ToppCell | metastatic_Brain-Endothelial_cells-Stalk-like_ECs|metastatic_Brain / Location, Cell class and cell subclass | 9.94e-05 | 185 | 22 | 3 | ad52970e88e8947ef256095bd4b40229b912d58a | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 187 | 22 | 3 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.06e-04 | 189 | 22 | 3 | aa4f7d7a5196e5ae481ebc2549de8e3f0ef6e6be | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|Fibroblasts / Location, Cell class and cell subclass | 1.08e-04 | 190 | 22 | 3 | d82ab67735c1f365d4b0e02b5fa91c64cdc234da | |
| ToppCell | BL-critical-LOC-Epithelial-Squamous|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.09e-04 | 191 | 22 | 3 | 3f9b8c4fb72ae6f3167b187e6715c4dcb3159f98 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.09e-04 | 191 | 22 | 3 | fbd8d337b4444fba8527a614e4a8bfb516ce0f66 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.09e-04 | 191 | 22 | 3 | 529068029fb461df766135576dd0d8b5980f9bc0 | |
| ToppCell | wk_15-18-Mesenchymal-Mesothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.09e-04 | 191 | 22 | 3 | b5374674312ff5803a1d369f5533027532344679 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.16e-04 | 195 | 22 | 3 | 82d87fdb39ec15be9057e2d2ba5c1afb5f97aafe | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.16e-04 | 195 | 22 | 3 | dd8117dbd22892288f74a7314ab0b5080106936c | |
| ToppCell | NS-critical-LOC-Epithelial-Squamous|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.18e-04 | 196 | 22 | 3 | 453c809494ceffa2a28af283c4b5a4924fcf160f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.20e-04 | 197 | 22 | 3 | ac9c0c25cfeaabd53d332982c73fc6c47b0c6478 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.20e-04 | 197 | 22 | 3 | b57d2e3413ef6dd1da56c45087926f2f3eab876c | |
| ToppCell | medial-Epithelial-Club|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.22e-04 | 198 | 22 | 3 | a861cf5bb1950ed5f0363b8a834a1c246e151389 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Basal_2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.22e-04 | 198 | 22 | 3 | 686eda427b075e788de38149eae82faf19bd5704 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.22e-04 | 198 | 22 | 3 | a54ae5275a510b49d7629f0908817a0c5f05020e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-04 | 198 | 22 | 3 | 77517df37dc894c78ef1e2b24dd7ba31f928bdb7 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.22e-04 | 198 | 22 | 3 | 34997e3896d0893fbe51bfb0d4660ccaca1c975e | |
| ToppCell | distal-2-Epithelial-Club|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.22e-04 | 198 | 22 | 3 | 3055c03896fbfac82a3072e51c0c54d68131cf1a | |
| ToppCell | medial-2-Epithelial-Club|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.22e-04 | 198 | 22 | 3 | 7f59d949190c10af13cbd13f81a795483deb9d14 | |
| ToppCell | medial-Epithelial-Club-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.22e-04 | 198 | 22 | 3 | da7881351a71cde926325ab3e22d772f64cfab80 | |
| ToppCell | 367C|World / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-04 | 198 | 22 | 3 | ab3a178f392204e2d90eb5a3b5de7849986b1eaf | |
| ToppCell | Biopsy_Other_PF-Epithelial-SCGB3A2+_SCGB1A1+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.23e-04 | 199 | 22 | 3 | 036244251d2dd39f8184b7095418c723c0524eff | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.23e-04 | 199 | 22 | 3 | 8be7cb9d8b4f9707efb69c681c40e683fcd810e5 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Basal_2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.25e-04 | 200 | 22 | 3 | 0fa3340d945f00ef55c7603476d51bd8346e82c2 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Col27a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.04e-04 | 43 | 22 | 2 | 52772889cdf2e47f703f1d6418da3dc9e5f7d933 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Adora2a-Excitatory_Neuron.Gad1Gad2.Adora2a-Nnat_(iSPN)|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.22e-04 | 54 | 22 | 2 | d21611ae38d34d62f855fa3797eb37a5d287a4a5 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Adora2a-Excitatory_Neuron.Gad1Gad2.Adora2a-Nnat_(iSPN)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.22e-04 | 54 | 22 | 2 | 20309afadc500f1485e86c62d8d38168c9253539 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Metaplastic_Carcinoma-2|TCGA-Breast / Sample_Type by Project: Shred V9 | 9.30e-04 | 92 | 22 | 2 | cad8b1b74a412988b2ae4f6126b2186100a2cdc2 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Recurrent_Tumor|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 9.30e-04 | 92 | 22 | 2 | b728c0faf742c9235b891e3acf34d18a0e335c22 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Recurrent_Tumor-Sarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 9.30e-04 | 92 | 22 | 2 | 207cde9de6f37b33e47bc6f9c32c9877ab7cbe63 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-7|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.03e-03 | 97 | 22 | 2 | 88ac93868312c9b57a1b23edc76b5907847d2c1d | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Tall_Cell-8|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.10e-03 | 100 | 22 | 2 | 082371eabc601317799345b69463f450b1a73166 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Basaloid_Squamous_Cell_Carcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.23e-03 | 106 | 22 | 2 | af3ac319e65f19f2f690a7e9db434c552893c5f1 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Basaloid_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.35e-03 | 111 | 22 | 2 | 6e539b74849cedbe599bb6b3b2f4ff7a01314630 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.39e-04 | 50 | 7 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_19_EPITHELIAL_SENESCENCE | |
| Drug | 4-tert-octylphenol | 5.25e-09 | 159 | 21 | 6 | ctd:C105260 | |
| Drug | beta-damascenone | 5.61e-09 | 24 | 21 | 4 | ctd:C075388 | |
| Drug | NSC19448 | 1.03e-04 | 273 | 21 | 4 | CID000003054 | |
| Drug | Diethylstilbestrol | 1.14e-04 | 1305 | 21 | 7 | ctd:D004054 | |
| Disease | atopic eczema | 1.78e-08 | 252 | 21 | 6 | EFO_0000274 | |
| Disease | vitamin D measurement | 9.80e-08 | 336 | 21 | 6 | EFO_0004631 | |
| Disease | childhood onset asthma | 3.16e-06 | 334 | 21 | 5 | MONDO_0005405 | |
| Disease | asthma | 1.04e-05 | 751 | 21 | 6 | MONDO_0004979 | |
| Disease | atopic asthma | 1.10e-05 | 199 | 21 | 4 | EFO_0010638 | |
| Disease | level of C-X-C motif chemokine 2 in blood serum | 3.17e-05 | 12 | 21 | 2 | OBA_2041207 | |
| Disease | level of C-X-C motif chemokine 3 in blood serum | 5.04e-05 | 15 | 21 | 2 | OBA_2041208 | |
| Disease | allergic disease, age at onset | 1.16e-03 | 71 | 21 | 2 | EFO_0004847, MONDO_0005271 | |
| Disease | cervical carcinoma | 7.36e-03 | 182 | 21 | 2 | EFO_0001061 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PPQSPPKNCTRNSCK | 261 | Q8WXH6 | |
| CPPQSPPKNCTRNSC | 261 | P0C0E4 | |
| CMSKDPCNPNPCQKN | 671 | O95980 | |
| PCNPNPCQKNQRCIP | 676 | O95980 | |
| PCQKNQRCIPKPQVC | 681 | O95980 | |
| PPKQNQCCQPKGSQC | 36 | P49901 | |
| PLPQPNTCKDNGPCK | 676 | P98095 | |
| CPQPVTEPQQCCPKC | 81 | Q6WN34 | |
| SQQQCQPPPKCTPKC | 6 | Q5T7P2 | |
| NQQQCQPPPKCIPKC | 6 | Q5T7P3 | |
| SQQQCQPPPKCTPKC | 6 | Q5T751 | |
| SQQQCQPPPKCTPKC | 6 | Q5T752 | |
| SQQQCQPPPKCTPKC | 6 | Q5T753 | |
| SQQQCQPPPKCTPKC | 6 | Q5T754 | |
| NQQQCQPPPKCPAKS | 6 | Q5TA76 | |
| SQQQCQPPPKCTPKC | 6 | Q5TCM9 | |
| VPLCAPNLCQPKQIC | 626 | Q99466 | |
| PCAPKCPPPQQCQTS | 91 | A0A1B0GTR4 | |
| QQCKQPCQPPPVCPT | 6 | P35326 | |
| QQCKQPCQPPPVCPT | 6 | P35325 | |
| QQCKQPCQPPPVCPT | 6 | P22532 | |
| QQCKQPCQPPPVCPT | 6 | P22531 | |
| CPQPCPPQQCQQKCP | 41 | P22531 | |
| CPPSKCPQSCPPQQC | 36 | Q96RM1 | |
| CPQSCPPQQCQQKCP | 41 | Q96RM1 | |
| QQCKQPCQPPPVCPT | 6 | Q9BYE4 | |
| CQDKCPPVQPYPPCQ | 51 | Q9BYE4 |